Staff Reports | Business & Commerce
Plexus Worldwide has received a patent from the United States Patent Office for its product Immune + in January 2025.
Based in Scottsdale since 2008, Plexus is an expert in gut health providing science-backed wellness products whereas the patent further solidifies the company’s commitment to using innovative and effective methods for promoting good health, according to a press release.
Plexus developed Immune + to support the body’s defense system.
The plant-based supplement, developed by Plexus’s in-house Research and Development team, received a utility patent for the formula, which includes black rice extract, prebiotic mushrooms, ascorbic acid, and an antioxidant blend, the release states.
“We secured this patent by proving our unique ingredient combination activates cytokines to influence immune response,” said Vice President of Research and Development at Plexus Worldwide Dr. Michael Hartman, PhD. “Human cell studies showed the Superfood blend in Immune + enhances immune response by encouraging normal immune cell activity.”
The U.S. Patent Office specifically recognized the products’ method for improving immunity and upper respiratory health. This adds to the growing list of patents and awards that Plexus has received for its innovative products, representatives of the brand tell the Digital Free Press.
